Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v10-EN
Language English English
Date Updated 2020-10-22 2020-10-22
Drug Identification Number 00176192 00176192
Brand name FIORINAL-C 1/4 FIORINAL-C 1/4
Common or Proper name acetylsalicylic acid- caffeine-codeine-butabital acetylsalicylic acid- caffeine-codeine-butabital
Company Name ARALEZ PHARMACEUTICALS CANADA INC ARALEZ PHARMACEUTICALS CANADA INC
Ingredients ACETYLSALICYLIC ACID BUTALBITAL CODEINE PHOSPHATE CAFFEINE ACETYLSALICYLIC ACID BUTALBITAL CODEINE PHOSPHATE CAFFEINE
Strength(s) 330MG 50MG 15MG 40MG 330MG 50MG 15MG 40MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size Bottles of 100 capsules Bottles of 100 capsules
ATC code N02AA N02AA
ATC description OPIOIDS OPIOIDS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-02-19 2020-02-19
Estimated end date
Actual end date 2020-10-21 2020-10-21
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments